A substantial body of evidence gathered from a variety of diseases points to a critical interaction between the sympathetic nervous system and the inflammatory cascade. An important sympathetic component to rheumatic disease is indicated by the observation that symptoms in both reflex sympathetic dystrophy and rheumatoid arthritis may be alleviated after regional sympathectomy. 1 Clearly, attempts to explain pathophysiological mechanisms must take observations such as these into account. This review summarises the evidence for a sympathetic influence on rheumatic disease and speculates on the mechanism by which this may arise. 4 This unfortunate state continued for months after the original wound had healed and was termed 'causalgia' by Mitchell and colleagues. 4 Since then a number of other terms have been used to describe disorders characterised by persistent pain, vasomotor disturbance, and trophic change. These include Sudeck's atrophy, shoulder-hand syndrome, algodystrophy, and reflex sympathetic dystrophy.5 Pathological mechanisms have yet to be clearly established, but three important clinical observations suggest that the sympathetic nervous system plays a part.6 As observed by Mitchell, pain in these disorders is exacerbated by stimuli that evoke sympathetic discharge, such as noise and emotional arousal. Secondly, the disorders are associated with vasomotor and sweating disturbances, suggestive of abnormal sympathetic activity. Finally, patients with these disorders often have a dramatic and prolonged response to guanethidine, reserpine, and other agents which alter sympathetic activity. ' Sympathectomy has also been used to treat rheumatoid arthritis. 2 Rheumatoid arthritis Sympathetic overactivity in reflex sympathetic dystrophy is associated with pain and juxtaarticular disease, including synovitis, and there appear to be important sympathetic influences on the outcome of experimental adjuvant arthritis. How then might these observations reflect pathogenic mechanisms in rheumatoid arthritis?
Clearly, normal human synovium is richly innervated with both sympathetic and afferent nerve fibres.3' Immunocytochemical studies using antisera against protein gene product 9.5 (PGP 9.5) as a marker for the overall innervation have shown fibres distributed around blood vessels and lying freely within synovium. Nearly all these nerves are immunoreactive for neuropeptides with neuropeptide Y immunoreactive fibres being exclusively located around blood vessels, whereas substance P and calcitonin gene related peptide immunoreactive fibres are located in both free and perivascular areas.3' The exact function of these peptides remains uncertain, but in addition to vascular regulation they probably play a part in immunoregulation and bone metabolism. 32 In rheumatoid arthritis the more superficial synovial tissues, including blood vessels and the intimal cell layer, are devoid of fibres immunoreactive for PGP 9.5 or any of the individual neuropeptides. 33 In deeper tissues the innervation is similar to normal tissues, but the immunostaining is weaker and fibres take on a beaded appearance with small lengths appearing unstained. A similar loss of immunoreactive fibres has also been seen in experimental models, including adjuvant arthritis. 34 The absence of immunoreactive fibres in the superficial layers of rheumatoid synovium might suggest that there is an increased release of substance P, calcitonin gene related peptide, and neuropeptide Y, which thereby reduces the neuronal stores to levels below that detectable by immunocytochemistry. As the immunostaining for the neuronal marker PGP 9.5 is also lost, however, it seems more probable that nerve fibres in the superficial layers are destroyed. 33 The loss of synovial nerves in rheumatoid arthritis is potentially caused by products of the inflammatory cascade. In studies using hypoxanthine/xanthine oxidase as a means of generating reactive oxygen species it is apparent that neuropeptides are vulnerable to damage. 35 Our own unpublished studies have shown rapid loss of synovial nerve fibres in a glucose oxidase model of inflammation which is known to depend on production of hydrogen peroxide. Exercised rheumatoid joints are subjected to 'intermittent' episodes of hypoxia, thus creating the conditions necessary for hypoxic-reperfusion events and the subsequent production of similarly destructive reactive oxygen species. 36 We speculate that a direct consequence of nerve damage in diseased joints is that synovial afferent fibres become sensitised to continuing sympathetic activity. This is supported by the observations made 
